Jupiter Neurosciences Inc... (JUNS)
Jupiter Neurosciences Statistics
Share Statistics
Jupiter Neurosciences has 33.1M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 33.1M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 14.54K |
| FTD / Avg. Volume | 2.08% |
Short Selling Information
The latest short interest is -, so null% of the outstanding shares have been sold short.
| Short Interest | - |
| Short % of Shares Out | null% |
| Short % of Float | null% |
| Short Ratio (days to cover) | null |
Valuation Ratios
The PE ratio is -37.73 and the forward PE ratio is null. Jupiter Neurosciences's PEG ratio is 0.
| PE Ratio | -37.73 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 9.8 |
| PB Ratio | -31.11 |
| P/FCF Ratio | -375.28 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Jupiter Neurosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of -0.39.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | -0.39 |
| Total Debt / Capitalization | -63.29 |
| Cash Flow / Debt | -0.21 |
| Interest Coverage | -17.7 |
Financial Efficiency
Return on equity (ROE) is 0.82% and return on capital (ROIC) is 108.95%.
| Return on Equity (ROE) | 0.82% |
| Return on Assets (ROA) | -32.19% |
| Return on Capital (ROIC) | 108.95% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,195,922.25 |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -81.5% in the last 52 weeks. The beta is 0, so Jupiter Neurosciences's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -81.5% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | 697.27K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -3.87M |
| Net Income | -4.78M |
| EBITDA | -4.56M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has 28.48K in cash and 2.25M in debt, giving a net cash position of -2.22M.
| Cash & Cash Equivalents | 28.48K |
| Total Debt | 2.25M |
| Net Cash | -2.22M |
| Retained Earnings | -23.58M |
| Total Assets | 85.55K |
| Working Capital | -5.68M |
Cash Flow
In the last 12 months, operating cash flow was -480.95K and capital expenditures 0, giving a free cash flow of -480.95K.
| Operating Cash Flow | -480.95K |
| Capital Expenditures | 0 |
| Free Cash Flow | -480.95K |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
JUNS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -20.27% |
| FCF Yield | -1.96% |
Analyst Forecast
Currently there are no analyst rating for JUNS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -561.28 |
| Piotroski F-Score | 3 |